We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 3,599

Second Circuit Deals Blow to Off-Label Marketing Claims
  • McDermott Will & Emery
  • USA
  • May 26 2016

On May 17, the United States Court of Appeals for the Second Circuit affirmed the dismissal of a relator's False Claims Act (FCA) claims predicated


First Circuit: Plaintiffs’ Specific Causation Expert Fails to Pass Muster in Benzene Case
  • Reed Smith LLP
  • USA
  • May 26 2016

Last week, we (along with many of you, we assume) attended the DRI Drug and Medical Device conference in Chicago. We re-connected with friends dating


Metal-on-metal hip implant supplier ordered to pay $500 million to five claimants who suffered injuries
  • Penningtons Manches LLP
  • USA
  • May 26 2016

A federal jury in Texas, USA, recently reached a verdict against Johnson & Johnson and its subsidiary DePuy, which has been ordered to pay $502


New York Reaffirms General Acceptance Standard in Frye for Scientific and Technical Issues
  • Wilson Elser
  • USA
  • May 26 2016

In a recent opinion handed down by New York's highest state court - the Court of Appeals -Sean R. v. BMW of N. Am., LLC, 2016 N.Y. Slip. Op. 01000


Toxic Tort & Product Liability Quarterly - May 25, 2016
  • Beveridge & Diamond PC
  • USA
  • May 25 2016

In a case that may make it easier to prove causation in Maryland lead paint cases, the Maryland Court of Appeals held that neither direct evidence of


Stick a Fork in It - FDA Anti-Generic Drug Preemption Proposal Postponed Until After the Presidential Election
  • Reed Smith LLP
  • USA
  • May 25 2016

On May 18, the FDA extended the comment period for its proposed generic drug labeling rule until April 2017 - that is, until after the next


Food and Beverage News and trends - 25 May 2016
  • DLA Piper LLP
  • USA
  • May 25 2016

This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal and regulatory landscape


Federal Court Determines that Patient Has Liberty Interest in Receiving Investigational Drug
  • Hogan Lovells
  • USA
  • May 24 2016

On May 17, 2016, a federal judge, citing arbitrary and capricious decisionmaking by FDA and notice-based due process concerns, granted a plaintiff's


Court Refuses to Invalidate San Francisco SSB-Warning Law
  • Shook Hardy & Bacon LLP
  • USA
  • May 20 2016

A California federal court has denied the American Beverage Association's (ABA's) attempt to preliminarily enjoin the enforcement of a law requiring


Weight-Loss Supplement Marketers Face Ban, Asset Forfeiture
  • Manatt Phelps & Phillips LLP
  • USA
  • May 19 2016

The marketers of weight-loss supplements containing green coffee bean extract agreed to forfeit assets totaling $9.2 million and to a ban on